Entity Common Stock, Shares Outstanding of THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. from 30 Jun 2011 to 20 Nov 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 30 Jun 2011 to 20 Nov 2024.
  • THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Entity Common Stock, Shares Outstanding for the quarter ending 20 Nov 2024 was 5,122,705,536.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 5,122,705,536 20 Nov 2024 10-Q 20 Nov 2024 2024 Q3
Q3 2024 4,884,095,275 +4,551,612,508 +1369% 19 Aug 2024 10-Q 19 Aug 2024 2024 Q2
Q2 2024 4,591,517,624 30 May 2024 10-Q 30 May 2024 2024 Q1
Q1 2024 4,230,116,869 +1,495,866,120 +55% 15 Apr 2024 10-K 17 Apr 2024 2023 FY
Q3 2023 332,482,767 -2,233,319,860 -87% 21 Aug 2023 10-Q 21 Aug 2023 2023 Q2
Q1 2023 2,734,250,749 +229,252,569 +9.2% 29 Mar 2023 10-K 29 Mar 2023 2022 FY
Q4 2022 2,608,288,008 +314,091,396 +14% 17 Nov 2022 10-Q 17 Nov 2022 2022 Q3
Q3 2022 2,565,802,627 17 Aug 2022 10-Q 19 Aug 2022 2022 Q2
Q2 2022 2,545,356,759 +281,721,182 +12% 20 May 2022 10-Q 23 May 2022 2022 Q1
Q1 2022 2,504,998,180 +260,545,110 +12% 29 Mar 2022 10-K 31 Mar 2022 2021 FY
Q4 2021 2,294,196,612 +94,172,462 +4.3% 19 Nov 2021 10-Q 22 Nov 2021 2021 Q3
Q2 2021 2,263,635,577 +316,197,085 +16% 13 Aug 2021 10-Q 13 Aug 2021 2021 Q2
Q1 2021 2,244,453,070 +587,908,765 +35% 07 Apr 2021 10-K/A 12 Apr 2021 2020 FY
Q4 2020 2,200,024,150 +760,986,503 +53% 16 Nov 2020 10-Q 17 Nov 2020 2020 Q3
Q3 2020 1,987,355,997 +574,964,815 +41% 19 Aug 2020 10-Q/A 24 Aug 2020 2020 Q2
Q2 2020 1,947,438,492 06 Jul 2020 10-Q/A 09 Jul 2020 2020 Q1
Q1 2020 1,656,544,305 +537,952,234 +48% 14 May 2020 10-K 21 May 2020 2019 FY
Q4 2019 1,439,037,647 18 Nov 2019 10-Q 20 Nov 2019 2019 Q3
Q3 2019 1,412,391,182 +483,238,430 +52% 16 Aug 2019 10-Q 16 Aug 2019 2019 Q2
Q1 2019 1,118,592,071 +17,490,000 +1.6% 14 May 2019 10-Q 20 May 2019 2019 Q1
Q3 2018 929,152,752 17 Aug 2018 10-Q 17 Aug 2018 2018 Q2
Q2 2018 800,165,450 +22,914,450 +2.9% 21 May 2018 10-Q/A 22 May 2018 2018 Q1
Q1 2018 1,101,102,071 +335,851,071 +44% 16 Apr 2018 10-K 15 Apr 2019 2018 FY
Q4 2017 806,501,000 15 Nov 2017 10-Q 16 Nov 2017 2017 Q3
Q2 2017 777,251,000 +94,500,000 +14% 05 Jul 2017 10-Q 05 Jul 2017 2017 Q1
Q1 2017 765,251,000 +92,300,000 +14% 13 Apr 2017 10-Q 13 Apr 2017 2016 Q2
Q3 2016 740,251,000 25 Oct 2016 10-K 31 Oct 2016 2015 FY
Q2 2016 682,751,000 30 Jun 2016 10-Q 06 Jul 2016 2015 Q1
Q1 2016 672,951,000 21 Apr 2016 10-K 22 Apr 2016 2013 FY
Q3 2013 89,466,400 -215,991,933 -71% 11 Nov 2013 10-Q 12 Nov 2013 2013 Q3
Q2 2013 89,466,400 12 Aug 2013 10-Q 12 Aug 2013 2013 Q2
Q1 2013 83,466,400 26 Mar 2013 10-K 29 Mar 2013 2012 FY
Q4 2012 305,458,333 26 Nov 2012 10-Q 29 Nov 2012 2012 Q3
Q3 2012 305,458,333 0 0% 15 Oct 2012 10-K 31 Oct 2012 2011 FY
Q3 2011 305,458,333 04 Nov 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 305,458,333 30 Jun 2011 10-Q/A 01 Sep 2011 2011 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.